📰 3 sources covering this story

STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more

First covered 1 days ago · latest take 47 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more
STAT News
STAT News47 mins ago
STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more
UniQure has submitted its Huntington’s gene therapy to the FDA, investors remain unenthusiastic on Novo Nordisk, and more of the latest pharma headlines in today's Pharmalittle newsletter.
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths  WSJ
Reuters
Reuters🏁 first to report1 days ago
Novartis pauses trials of experimental cell therapy after three deaths
Novartis pauses trials of experimental cell therapy after three deaths  Reuters
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →